英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
295945查看　295945　在百度字典中的解释百度英翻中〔查看〕
295945查看　295945　在Google字典中的解释Google英翻中〔查看〕
295945查看　295945　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Eltrombopag | Drugs | BNF | NICE
    View eltrombopag information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, monitoring requirements and important safety information
  • Revolade 75 mg film-coated tablets - Summary of Product . . . - medicines
    Eltrombopag treatment should be initiated by and remain under the supervision of a physician who is experienced in the treatment of haematological diseases or the management of chronic hepatitis C and its complications Posology Eltrombopag dosing requirements must be individualised based on the patient's platelet counts
  • Eltrombopag - Wikipedia
    Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia [3] [4] Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis [6] It is a thrombopoietin receptor agonist [3] It is taken by mouth [3] [4]
  • Eltrombopag for treating chronic immune thrombocytopenia
    Evidence-based recommendations on eltrombopag (Revolade) for treating chronic immune thrombocytopenia in adults Last reviewed: 26 October 2018 We updated the recommendations because the marketing authorisation for eltrombopag now includes people who have not had a splenectomy
  • Eltrombopag, a thrombopoietin- receptor agonist in the treatment of . . .
    Eltrombopag is an orally administered small-molecule nonpeptide TPO-R agonist It has been shown to effectively increase platelet counts and reduce bleeding symptoms in patients with chronic ITP with overall response rate of 60–80% Eltrombopag is well tolerated and has a good safety profile
  • Eltrombopag Viatris | European Medicines Agency (EMA)
    Eltrombopag Viatris is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (ITP) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e g corticosteroids, immunoglobulins) (see sections 4 2 and 5 1)
  • Eltrombopag: Side Effects, Dosage, Uses, and More - Healthline
    Eltrombopag is a prescription used to treat low platelet levels due to chronic immune thrombocytopenia (ITP) or chronic hepatitis C virus infection Learn more
  • Eltrombopag Uses, Side Effects Warnings - Drugs. com
    What is eltrombopag? This medication guide only provides information about certain brand forms of eltrombopag Eltrombopag is used to treat low platelet levels in adults and children at least 1 year old with chronic immune thrombocytopenia Eltrombopag is given after other treatments did not work or stopped working
  • Eltrombopag: Uses, Interactions, Mechanism of Action - DrugBank Online
    Eltrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies Eltrombopag is used to treat low blood platelet counts in adults with chronic immune (idiopathic) thrombocytopenia (ITP), when certain other medicines, or surgery to remove the spleen, have not worked well enough
  • Eltrombopag: Comprehensive Guide to Thrombocytopenia Treatment
    Eltrombopag is a prescription medication used to treat low platelet counts in conditions such as chronic immune thrombocytopenic purpura (ITP), aplastic anemia, and thrombocytopenia related to hepatitis C or liver disease It works by stimulating the production of platelets in the bone marrow





中文字典-英文字典  2005-2009